Versant Venture Management as of March 31, 2018
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 67.3 | $211M | 4.6M | 45.71 | |
| Audentes Therapeutics | 11.6 | $36M | 1.2M | 30.05 | |
| Achaogen | 5.3 | $17M | 1.3M | 12.95 | |
| Ocular Therapeutix (OCUL) | 4.6 | $14M | 2.2M | 6.51 | |
| Cymabay Therapeutics | 4.4 | $14M | 1.0M | 12.99 | |
| Second Sight Med Prods | 2.8 | $8.6M | 4.5M | 1.92 | |
| Immune Design | 2.3 | $7.3M | 2.2M | 3.30 | |
| Clovis Oncology | 1.7 | $5.4M | 102k | 52.80 |
